Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration
Michael F. Kanan, Patrick W. Sheehan, Jessica N. Haines, Pedro G. Gomez, Adya Dhuler, Collin J. Nadarajah, Zachary M. Wargel, Brittany M. Freeberg, Hemanth R. Nelvagal, Mariko Izumo, Joseph S. Takahashi, Jonathan D. Cooper, Albert A. Davis, Erik S. Musiek
Michael F. Kanan, Patrick W. Sheehan, Jessica N. Haines, Pedro G. Gomez, Adya Dhuler, Collin J. Nadarajah, Zachary M. Wargel, Brittany M. Freeberg, Hemanth R. Nelvagal, Mariko Izumo, Joseph S. Takahashi, Jonathan D. Cooper, Albert A. Davis, Erik S. Musiek
View: Text | PDF | Corrigendum
Research Article Aging Neuroscience

Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration

  • Text
  • PDF
Abstract

Circadian rhythm dysfunction is a hallmark of Parkinson disease (PD), and diminished expression of the core clock gene Bmal1 has been described in patients with PD. BMAL1 is required for core circadian clock function but also serves nonrhythmic functions. Germline Bmal1 deletion can cause brain oxidative stress and synapse loss in mice, and it can exacerbate dopaminergic neurodegeneration in response to the toxin MPTP. Here we examined the effect of cell type–specific Bmal1 deletion on dopaminergic neuron viability in vivo. We observed that global, postnatal deletion of Bmal1 caused spontaneous loss of tyrosine hydroxylase+ (TH+) dopaminergic neurons in the substantia nigra pars compacta (SNpc). This was not replicated by light-induced disruption of behavioral circadian rhythms and was not induced by astrocyte- or microglia-specific Bmal1 deletion. However, either pan-neuronal or TH neuron–specific Bmal1 deletion caused cell-autonomous loss of TH+ neurons in the SNpc. Bmal1 deletion did not change the percentage of TH neuron loss after α-synuclein fibril injection, though Bmal1-KO mice had fewer TH neurons at baseline. Transcriptomics analysis revealed dysregulation of pathways involved in oxidative phosphorylation and Parkinson disease. These findings demonstrate a cell-autonomous role for BMAL1 in regulating dopaminergic neuronal survival and may have important implications for neuroprotection in PD.

Authors

Michael F. Kanan, Patrick W. Sheehan, Jessica N. Haines, Pedro G. Gomez, Adya Dhuler, Collin J. Nadarajah, Zachary M. Wargel, Brittany M. Freeberg, Hemanth R. Nelvagal, Mariko Izumo, Joseph S. Takahashi, Jonathan D. Cooper, Albert A. Davis, Erik S. Musiek

×

Figure 5

Tyrosine hydroxylase–specific Bmal1 deletion induces dopaminergic neuron degeneration and increased microgliosis.

Options: View larger image (or click on image) Download as PowerPoint
Tyrosine hydroxylase–specific Bmal1 deletion induces dopaminergic neuron...
(A) TH (red) and BMAL1 (green) staining in the SNpc of Cre–;Bmalfl/fl control and TH-Cre;Bmalfl/fl TH-specific Bmal1-KO mice. Insets show loss of nuclear BMAL1 staining in a subset of TH+ neurons from Cre+ mice. Scale bar: 150 μm. (B) TH staining in striatum of TH-Cre– and Cre+ mice. Scale bar: 200 μm. (C) Quantification of BMAL1+/TH+ neurons within the SNpc of Cre– control and Cre+ TH-specific Bmal1-KO mice. n = 6 mice per genotype. (D) Stereological counts of TH+ cells within the SNpc of Cre– control and Cre+ TH-specific Bmal1-KO mice. n = 6 mice per genotype. (E) Quantification of TH immunoreactivity (IR) in striatum, as shown in B. n = 6 mice per genotype. (F) Representative images of TH+ neurons (red) and microglia (Iba1, green) within the SNpc of Cre– control and Cre+ TH-specific Bmal1-KO mice. Representative skeletonized microglia reconstructions are shown in the right panels. Scale bar: 60 μm. Graph indicates average branches per microglial cell within the SNpc of Cre– control and Cre+ TH-specific Bmal1-KO mice. n = 6 mice per genotype, n = 9–10 microglia per mouse. (G) Representative actrograms showing activity rhythms of TH-Cre– and Cre+ mice over 32 days. Yellow indicates lights on. (H) Quantification of period (left) and relative amplitude (right) from actigraphy in G, calculated using data from the 12:12 lights on (L:D) or constant darkness (D:D) periods. For Period and Relative amplitude, no significant main effect of Cre genotype or interaction were observed by 2-way ANOVA. n = 5 mice/genotype. For all panels, each circle represents average data from a single mouse. For C–F, *P < 0.05, **P < 0.01, ***P < 0.001 by 2-tailed t test. In all panels, data represent mean ± SEM. All fold changes normalized to average of Cre– condition.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts